Hospital
Temple University Hospital, INC
Temple University Hospital, INC was paid $13.60M by Medicaid between Feb 2020 and Dec 2024, across 195 billing codes. Its largest line is 99283, emergency room visit (moderate) — 30% of everything it billed.
33Billing provider infoTEMPLE UNIVERSITY HOSPITAL, INC
PHILADELPHIA, PA 19111
PHILADELPHIA, PA 19111
33aNPI1356981443assigned 01/07/2020
33bProvider typeGeneral Acute Care Hospital
28Total paid$13.60M
24GClaims146,464
24DCodes billed195
24AFirst – last monthFeb 2020 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Pennsylvania
Rank by total paid#24 of 154
Median peer was paid$2.82M
This provider vs. median4.8×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 19,120 | $1.21M | |
| 2021 | 55,950 | $4.88M | |
| 2022 | 18,373 | $3.79M | |
| 2023 | 24,628 | $1.91M | |
| 2024incomplete | 28,393 | $1.80M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 30% | 14,386 | 13,553 | $4.06M |
| G0378 | Hospital observation service, per hour | 27% | 1,952 | 1,755 | $3.62M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 26% | 13,168 | 12,257 | $3.50M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 2.1% | 2,013 | 1,859 | $291K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 1.8% | 3,361 | 3,290 | $243K |
| 62323 | 1.8% | 425 | 404 | $243K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 1.6% | 2,115 | 2,093 | $223K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1.2% | 1,077 | 1,056 | $166K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 580 | 558 | $111K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 413 | 399 | $75K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | <1% | 632 | 623 | $57K |
| G0399 | Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | <1% | 368 | 357 | $52K |
183 more codes
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 732 | $50K |
| 76830 | Ultrasound, transvaginal | <1% | 827 | $48K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 197 | $48K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 452 | $46K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 954 | $42K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 136 | $40K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 2,416 | $36K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 6,713 | $36K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 183 | $36K |
| 76536 | <1% | 525 | $35K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 593 | $33K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 2,386 | $33K |
| 71250 | <1% | 374 | $26K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 106 | $25K |
| 93975 | <1% | 251 | $24K | |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 423 | $22K |
| 93017 | <1% | 321 | $21K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 25 | $18K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 280 | $18K |
| 93970 | <1% | 186 | $16K | |
| 93000 | <1% | 789 | $14K | |
| 81025 | <1% | 512 | $13K | |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 27 | $11K |
| 76770 | <1% | 213 | $11K | |
| 72141 | <1% | 40 | $11K | |
| 76642 | <1% | 178 | $9K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 465 | $8K |
| 99205 | Prolong outpt/office vis | <1% | 76 | $8K |
| 93976 | <1% | 87 | $8K | |
| 80053 | Comprehensive metabolic panel | <1% | 3,314 | $7K |
| 20610 | <1% | 12 | $7K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 31 | $7K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 205 | $7K |
| 93296 | <1% | 361 | $7K | |
| 77080 | <1% | 142 | $7K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 3,009 | $6K |
| 73564 | <1% | 361 | $6K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 169 | $6K |
| 93971 | <1% | 99 | $6K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 134 | $6K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 107 | $6K |
| 71045 | Radiologic examination, chest; single view | <1% | 1,630 | $5K |
| 94729 | <1% | 140 | $5K | |
| 76775 | <1% | 92 | $5K | |
| 72100 | <1% | 179 | $5K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 3,909 | $5K |
| 94726 | <1% | 130 | $4K | |
| 0002A | <1% | 75 | $4K | |
| A9579 | Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | <1% | 579 | $4K |
| 74178 | <1% | 14 | $4K | |
| 73221 | <1% | 14 | $4K | |
| 73030 | <1% | 237 | $3K | |
| 0003A | <1% | 171 | $3K | |
| 74246 | <1% | 66 | $3K | |
| 84703 | <1% | 3,417 | $3K | |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | <1% | 25 | $3K |
| 0001A | <1% | 68 | $3K | |
| A9270 | Non-covered item or service | <1% | 5,787 | $3K |
| 72110 | <1% | 110 | $3K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 5,601 | $3K |
| 94618 | <1% | 103 | $3K | |
| 94060 | <1% | 128 | $3K | |
| 77065 | Tomosynthesis, mammo | <1% | 29 | $2K |
| 73630 | <1% | 262 | $2K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 602 | $2K |
| U0001 | Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel | <1% | 304 | $2K |
| 85027 | <1% | 1,781 | $2K | |
| 84484 | <1% | 2,539 | $2K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 246 | $2K |
| 73610 | <1% | 147 | $2K | |
| 73130 | <1% | 173 | $2K | |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results | <1% | 41 | $2K |
| 76376 | <1% | 287 | $2K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 693 | $2K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 260 | $1K |
| 77066 | Tomosynthesis, mammo | <1% | 14 | $1K |
| 82803 | <1% | 205 | $1K | |
| 77002 | <1% | 90 | $1K | |
| 82248 | <1% | 187 | $1K | |
| 82247 | <1% | 163 | $846.29 | |
| 73502 | <1% | 44 | $787.50 | |
| 82948 | <1% | 1,684 | $724.85 | |
| 85730 | <1% | 588 | $661.36 | |
| 73523 | <1% | 17 | $579.10 | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 29 | $572.93 |
| 80061 | Lipid panel | <1% | 210 | $572.91 |
| 81001 | <1% | 890 | $568.68 | |
| 86850 | <1% | 350 | $553.89 | |
| Q0092 | Set-up portable x-ray equipment | <1% | 971 | $544.29 |
| 93922 | <1% | 15 | $539.45 | |
| 73560 | <1% | 31 | $537.41 | |
| 85610 | <1% | 698 | $522.08 | |
| 83690 | <1% | 873 | $500.94 | |
| 83880 | <1% | 202 | $463.65 | |
| 83735 | <1% | 967 | $443.86 | |
| 81003 | <1% | 1,687 | $443.27 | |
| 80323 | <1% | 24 | $409.63 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 64 | $403.60 |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 17 | $400.10 |
| 95819 | <1% | 14 | $360.54 | |
| 97162 | <1% | 18 | $296.56 | |
| 86901 | <1% | 412 | $286.66 | |
| 86900 | <1% | 414 | $283.21 | |
| 85007 | <1% | 460 | $274.06 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 212 | $270.44 |
| 87070 | <1% | 249 | $265.01 | |
| 87040 | <1% | 163 | $261.38 | |
| 84702 | <1% | 116 | $259.69 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 379 | $237.95 |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 2,151 | $233.00 |
| 93041 | <1% | 45 | $224.63 | |
| 85379 | <1% | 357 | $219.36 | |
| 82962 | <1% | 118 | $214.18 | |
| J3490 | Unclassified drugs | <1% | 2,364 | $204.82 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,849 | $203.38 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 89 | $200.39 |
| 83605 | <1% | 289 | $195.25 | |
| 88342 | <1% | 27 | $181.81 | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 869 | $177.40 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 189 | $173.46 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 189 | $173.46 |
| J2704 | Injection, propofol, 10 mg | <1% | 2,250 | $149.96 |
| 80367 | <1% | 14 | $136.60 | |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 1,931 | $121.68 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 433 | $113.42 |
| Q3014 | Telehealth originating site facility fee | <1% | 12 | $111.72 |
| 87186 | <1% | 142 | $109.35 | |
| 93294 | <1% | 15 | $87.30 | |
| 93295 | <1% | 29 | $85.59 | |
| 84100 | <1% | 336 | $82.82 | |
| 86803 | <1% | 94 | $80.88 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 2,216 | $72.67 |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 1,483 | $67.37 |
| 82550 | <1% | 102 | $67.07 | |
| 80076 | <1% | 252 | $66.40 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 960 | $59.31 |
| 90714 | <1% | 12 | $50.20 | |
| 87077 | <1% | 131 | $38.12 | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 13 | $27.30 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 3,121 | $24.06 |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | <1% | 73 | $18.37 |
| 87400 | <1% | 44 | $18.27 | |
| 97116 | <1% | 27 | $16.36 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 2,068 | $15.60 |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | <1% | 99 | $13.61 |
| 88304 | <1% | 30 | $12.42 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 2,951 | $11.88 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 802 | $5.82 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 12 | $5.79 |
| 94760 | <1% | 34 | $4.04 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 427 | $3.46 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 444 | $2.29 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 632 | $1.20 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 50 | $0.56 |
| G9920 | Screening performed and negative | <1% | 17 | $0.01 |
| J3370 | Injection, vancomycin hcl, 500 mg | 0% | 84 | $0.00 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 0% | 652 | $0.00 |
| J1596 | Injection, glycopyrrolate, 0.1 mg | 0% | 61 | $0.00 |
| C9113 | Injection, pantoprazole sodium, per vial | 0% | 305 | $0.00 |
| S0028 | Injection, famotidine, 20 mg | 0% | 266 | $0.00 |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 0% | 33 | $0.00 |
| J1650 | Injection, enoxaparin sodium, 10 mg | 0% | 835 | $0.00 |
| J1171 | Injection, hydromorphone, 0.1 mg | 0% | 41 | $0.00 |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | 0% | 46 | $0.00 |
| 0004A | 0% | 83 | $0.00 | |
| J1817 | Insulin for administration through dme (i.e., insulin pump) per 50 units | 0% | 524 | $0.00 |
| J8540 | Dexamethasone, oral, 0.25 mg | 0% | 464 | $0.00 |
| J1815 | Injection, insulin, per 5 units | 0% | 506 | $0.00 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 0% | 245 | $0.00 |
| J2371 | Injection, phenylephrine hydrochloride, 20 micrograms | 0% | 285 | $0.00 |
| 36415 | Collection of venous blood by venipuncture | 0% | 53 | $0.00 |
| Q9965 | Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml | 0% | 199 | $0.00 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 0% | 173 | $0.00 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 0% | 274 | $0.00 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 0% | 12 | $0.00 |
| S0020 | Injection, bupivicaine hydrochloride, 30 ml | 0% | 50 | $0.00 |
| J2471 | Injection, pantoprazole (hikma), not therapeutically equivalent to j2470, 40 mg | 0% | 17 | $0.00 |
| J7644 | Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram | 0% | 83 | $0.00 |
| J2785 | Injection, regadenoson, 0.1 mg | 0% | 102 | $0.00 |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | 0% | 31 | $0.00 |
| 94761 | 0% | 25 | $0.00 | |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 0% | 13 | $0.00 |
| 87205 | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSNYDER, CHRISTOPHER (CFO)
Parent organizationTEMPLE UNIVERSITY HOSPITAL, INC
| Provider | Location | Paid |
|---|---|---|
| Temple University Hospital, INC | Philadelphia, PA | $116.55M |
| Temple University Hospital, INC - Psych Unit | Philadelphia, PA | $22.27M |
| Temple University Hospital, INC | Philadelphia, PA | $4.01M |
| CHH Community Health | Philadelphia, PA | $3.55M |
| Temple University Hospital, INC | Philadelphia, PA | $9K |
| Temple University Hospital, INC | Philadelphia, PA | $0.00 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.